Thompson Siegel & Walmsley LLC Jazz Pharmaceuticals PLC Transaction History

Thompson Siegel & Walmsley LLC

$6.71 Billion
Q3 2024

A detailed history of Thompson Siegel & Walmsley LLC transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Thompson Siegel & Walmsley LLC holds 781,215 shares of JAZZ stock, worth $97.1 Million. This represents 1.3% of its overall portfolio holdings.

Number of Shares

781,215

Previous 721,530 8.27%

Holding current value

$97.1 Million

Previous $77 Million 13.02%

% of portfolio

1.3%

Previous 1.23%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$100.57 - $116.37 $6 Million - $6.95 Million	59,685 Added 8.27%	781,215 $87 Million
Q2 2024 Aug 08, 2024	BUY	$103.94 - $118.98 $17.6 Million - $20.1 Million	168,957 Added 30.58%	721,530 $77 Million
Q1 2024 May 09, 2024	BUY	$115.19 - $132.77 $23 Million - $26.6 Million	200,011 Added 56.73%	552,573 $66.5 Million
Q4 2023 Feb 07, 2024	BUY	$114.26 - $136.0 $9.37 Million - $11.2 Million	81,988 Added 30.3%	352,562 $43.4 Million
Q3 2023 Nov 08, 2023	BUY	$122.0 - $145.31 $23.4 Million - $27.8 Million	191,648 Added 242.82%	270,574 $35 Million
Q2 2023 Aug 10, 2023	BUY	$122.5 - $147.16 $9.63 Million - $11.6 Million	78,619 Added 25608.79%	78,926 $9.78 Million
Q4 2022 Feb 10, 2023	BUY	$129.72 - $159.85 $39,824 - $49,073	307 New	307 $48,000
Q1 2022 Apr 26, 2022	SELL	$129.64 - $160.7 $19,186 - $23,783	-148 Reduced 32.53%	307 $48,000
Q4 2021 Feb 09, 2022	SELL	$119.87 - $145.67 $1,438 - $1,748	-12 Reduced 2.57%	455 $58,000
Q3 2021 Nov 05, 2021	SELL	$128.64 - $184.79 $1,672 - $2,402	-13 Reduced 2.71%	467 $61,000
Q2 2021 Aug 09, 2021	BUY	$160.2 - $186.42 $16,821 - $19,574	105 Added 28.0%	480 $85,000
Q1 2021 May 07, 2021	SELL	$150.19 - $173.5 $37.4 Million - $43.2 Million	-248,930 Reduced 99.85%	375 $62,000
Q4 2020 Feb 08, 2021	BUY	$140.71 - $165.05 $2.4 Million - $2.81 Million	17,027 Added 7.33%	249,305 $41.1 Million
Q3 2020 Nov 12, 2020	SELL	$105.46 - $144.13 $10.2 Million - $13.9 Million	-96,247 Reduced 29.3%	232,278 $33.1 Million
Q2 2020 Aug 11, 2020	BUY	$95.68 - $121.88 $31.4 Million - $40 Million	328,525 New	328,525 $36.3 Million
Q1 2020 May 12, 2020	SELL	$87.74 - $152.74 $438 - $763	-5 Closed	0 $0
Q4 2019 Feb 07, 2020	BUY	$117.65 - $153.73 $588 - $768	5 New	5 $1,000

Others Institutions Holding JAZZ

# of Institutions

510

Shares Held

57.8M

Call Options Held

188K

Put Options Held

133K

View Full List

About Jazz Pharmaceuticals plc

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.79B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

More about JAZZ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Thompson Siegel & Walmsley LLC, based on Form 13F filings with the SEC.

News

Stay updated on Thompson Siegel & Walmsley LLC with notifications on news.

Account

Thompson Siegel & Walmsley LLC Jazz Pharmaceuticals PLC Transaction History